We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing

By LabMedica International staff writers
Posted on 01 Mar 2023
Print article
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)
Image: The global urinalysis market is expected to reach USD 6.5 billion in 2030 (Photo courtesy of Pexels)

The global urinalysis market is projected to grow at a CAGR of 6.7% from USD 1.87 billion in 2021 to USD 2.87 billion by 2030, driven by the rising incidence of kidney and urinary tract disorders, growing demand for point-of-care diagnostic testing, increase in aging population and higher healthcare expenditure. In addition, the increasing prevalence of chronic diseases such as diabetes and hypertension, which are linked to kidney and urinary tract disorders, accompanied by technological advancements in urinalysis testing equipment, such as the development of automated urinalysis systems, is expected to fuel market growth.

These are the latest findings of Emergen Research (Vancover, BC, Canada), a market research and consulting company.

The increasing prevalence of kidney diseases and urinary tract infections, particularly among elderly individuals, is a key factor driving the urinalysis market growth. This has been accompanied by the rising occurrences of chronic conditions like diabetes and hypertension, leading to higher incidences of kidney and urinary tract conditions. Additionally, there is an increase in demand for point-of-care diagnostic tests, spurring the development of sophisticated urinalysis testing devices. These devices deliver accurate results quickly, making them a great option for use in ERs, outpatient clinics and other healthcare settings. Technology has also enabled the production of automated urinalysis systems which provide fast and precise results, making them perfect for high-throughput clinical laboratories.

Nevertheless, the market growth could be hindered by the high costs of automated urinalysis systems and other diagnostic testing devices. Additionally, a lack of skilled professionals to carry out diagnostic tests, especially in developing countries, could also impede market growth. Inaccurate results obtained from some urinalysis tests which can lead to misdiagnosis and inadequate treatment can also have a negative impact on market growth. Moreover, the absence of standardization in urinalysis testing processes could affect market growth, as different methods can result in different outcomes, making it difficult to compare results from different labs.

Currently, the urinalysis market is experiencing several trends and innovations including the emergence of advanced urinalysis testing devices and the growing use of point-of-care diagnostic tests. The use of AI and machine learning for urinalysis testing is also a trend that is likely to become more popular in the future. Furthermore, with the increasing demand for easy-to-use portable urinalysis test equipment, particularly in low-income settings, manufacturers are producing innovative devices that are cost-effective and require minimal training to operate.

Geographically, North America is expected to hold the largest revenue share in the global urinalysis market during the forecast period due to the rising prevalence of chronic renal disease, hypertension and diabetes, well-established sophisticated healthcare systems, and significant healthcare expenditure in the region. The European urinalysis market is expected to register a steady revenue growth over the forecast period owing to beneficial reimbursement policies and government guidelines and regulations, as well as developed healthcare infrastructure in the region. The Asia Pacific urinalysis market is expected to register a high revenue growth over the forecast period, thanks to the rapidly developing healthcare industry and increasing investments by key market players.

Related Links:
Emergen Research

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The cobas Malaria test is the first FDA-approved molecular test to screen U.S. blood donors for malaria (Photo courtesy of Roche)

First FDA-Approved Molecular Test to Screen Blood Donors for Malaria Could Improve Patient Safety

Malaria, a serious illness that often leads to death, is spread by a specific mosquito species that infect humans with a parasite. Other transmission modes include blood transfusions, organ transplants,... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The medical office procedure detects the key biomarker in Parkinson’s and related neurodegenerative diseases (Photo courtesy of BIDMC)

Simple Skin Biopsy Test Detects Parkinson’s and Related Neurodegenerative Diseases

Parkinson's disease and a group of related neurodegenerative disorders known as synucleinopathies impact millions globally. These conditions, including Parkinson’s disease (PD), dementia with Lewy bodies... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.